Applications of DL-Leucyl-DL-Phenylalanine in Industrial Manufacturing

DL-Leucyl-DL-Phenylalanine serves as a specialty dipeptide utilized by production facilities in highly regulated sectors. The following sections outline the main downstream environments where our material delivers process-specific performance. Each scenario reflects direct industrial practice, addressing compliance, formulation dosing, integration workflows, and resulting finished goods.

1. Pharmaceutical Peptide Synthesis

Peptide drug manufacturers deploy DL-Leucyl-DL-Phenylalanine as a protected building block within solid-phase peptide synthesis (SPPS), where it supports the creation of complex therapeutic sequences. As an intermediate, it allows for orthogonal deprotection strategies and efficient elongation of active pharmaceutical ingredient (API) chains. Integration centers on precise coupling and deprotection steps controlled under GMP and pharmacopoeial environments.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• United States Pharmacopeia (USP) General Chapter <797>
• European Pharmacopoeia 11.0 monographs for peptides
• FDA 21 CFR Part 210/211 cGMP for finished pharmaceuticals

Typical usage ratio

• Ranges from 1–2% by weight relative to resin loading in SPPS. Actual dosing depends on peptide sequence length and side chain protection strategy.

Downstream process integration

• We supply this dipeptide for direct use during the peptide chain assembly. Technicians dissolve pre-measured quantities in DMF or NMP, followed by activation and sequential incorporation into the growing peptide via automated or manual reactors.

Final product types

• Peptide active pharmaceutical ingredients (APIs)
• Injectable peptide formulations
• Nasally or orally delivered peptide pharmaceuticals

2. Reference Standards for Analytical Laboratories

Analytical method development companies use our dipeptide as a traceable reference standard for quantifying peptide chain purity during QC and validation. Its well-defined structure and stability profile make it indispensable for LC-MS, HPLC, and amino acid analysis workflows, supporting batch release and regulatory dossiers for peptide APIs.

Industry compliance standards

• ISO/IEC 17025:2017 General Requirements for Testing and Calibration Laboratories
• Ph. Eur. 2.2.29 / USP <621> Chromatography validation
• GLP (Good Laboratory Practice) OECD Principles
• FDA Guidance for Chemistry, Manufacturing and Controls

Typical usage ratio

• Used at 0.1–1 mg/mL in eluents or as spiking controls, with the precise concentration dictated by the sensitivity curve for the specific detector.

Downstream process integration

• The dipeptide is weighed and dissolved into high-purity solvents, forming calibration or system suitability standards for peptide analytical runs. QC teams employ it for calibration curve generation, instrument qualification, and method linearity checks prior to large-batch release testing.

Final product types

• Laboratory reference standards for peptide QC
• Calibration solutions for liquid chromatography
• Peptide quantification kits supplied to regulated manufacturers

3. Specialty Nutritional Ingredient Production

Producers in the medical nutrition and specialized supplement space incorporate our dipeptide as a model compound during amino acid balance studies and in tailor-made protein hydrolysate formulations. It provides a controlled dipeptide source for metabolic testing and special dietary supplements for clinical and research settings.

Industry compliance standards

• Codex Alimentarius Guidelines for Food for Special Medical Purposes (FSMP)
• ISO 22000:2018 Food Safety Management Systems
• EFSA regulation (EU) No 609/2013 for foods for specific groups
• FDA 21 CFR Part 105, 107 – Infant Formula and Medical Foods

Typical usage ratio

• Applied at 0.05–0.5% w/w in medical nutrition prototypes or test matrices, with the exact content based on experimental protocol, diet formulation, and target protein equivalent.

Downstream process integration

• Technologists add the dipeptide into water or carbohydrate carriers and thoroughly homogenize under nitrogen to prevent oxidation. The ingredient is then pasteurized or aseptically filled depending on final dosage format for clinical trials or metabolic feeding studies.

Final product types

• Enteral amino acid supplement blends
• Medical nutrition prototype drinks
• Research-grade feeding trial products

4. Cosmetic Peptide Ingredient Manufacturing

Formulators in the cosmeceutical sector utilize the dipeptide as part of experimental active ingredient synthesis programs targeting anti-aging and barrier-repair applications. The material acts as a fragment donor during cosmetic hexapeptide or oligopeptide synthesis, ensuring tight identity and purity control for skincare actives with defined efficacy markers.

Industry compliance standards

• ISO 22716:2007 Good Manufacturing Practices for Cosmetics
• EU Regulation (EC) No 1223/2009 on Cosmetic Products
• Regulation (EC) No 1907/2006 (REACH) for chemical safety
• China GB 7916 Hygienic Standard for Cosmetics

Typical usage ratio

• In multi-peptide cosmetic actives, typical proportions are 0.1–1.2% by mass in the pre-assembled peptide concentrate, with exact input based on target peptide configuration and batch scale.

Downstream process integration

• Production engineers dissolve the dipeptide with other amino acid fragments and activate with coupling agents. The synthesized multipeptide complex is subsequently purified and standardized for incorporation into finished serums, creams, or sheet masks under controlled environmental conditions.

Final product types

• Anti-aging peptide serums
• Barrier-repair facial masks
• Cosmetic ingredient actives for skin application